Davide Tore

Dr. Davide Tore

Radiology Unit, Department of Surgical Sciences, University of Turin, Turin, Piedmont, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2023 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
GGGuglielmo Gallone
Guglielmo Gallone
MBMatteo Bellettini
Matteo Bellettini
MGMarco Gatti
Marco Gatti
Davide ToreDavide Tore
Davide Tore
FBFrancesco Bruno
Francesco Bruno
Fabrizio D'AscenzoFabrizio D'Ascenzo
Fabrizio D'Ascenzo

26 June 2020 in World Journal of Cardiology
Verified
Journal Article
Open access
MGMarco Gatti
Marco Gatti
ACAndrea Carisio
Andrea Carisio
TDTommaso D’aNgelo
Tommaso D’aNgelo
FDFatemeh Darvizeh
Fatemeh Darvizeh
SDSerena Dell’aVersana
Serena Dell’aVersana
RFRiccardo Faletti
Riccardo Faletti
Cardiovascular magnetic resonance in myocardial infarction with non-obstructive coronary arteries patients: A review

1 May 2022 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
GGGuglielmo Gallone
Guglielmo Gallone
ADAlessandro Depaoli
Alessandro Depaoli
FDFabrizio D'AScenzo
Fabrizio D'AScenzo
Davide ToreDavide Tore
Davide Tore
LALuca Allois
Luca Allois
GFGaetano M. De Ferrari
Gaetano M. De Ferrari

19 June 2023 in Heliyon
Verified
Journal Article
Open access
Davide ToreDavide Tore
Davide Tore
RFRiccardo Faletti
Riccardo Faletti
CGClara Gaetani
Clara Gaetani
EBElena Bozzo
Elena Bozzo
ABAndrea Biondo
Andrea Biondo
MGMarco Gatti
Marco Gatti
Hypertrophic heart phenotype is characterized by an abnormal left ventricular (LV) thickening. A hypertrophic phenotype can develop as adaptive response in many different conditions such as aortic stenosis, hypertension, athletic training, infiltrative heart muscle diseases, storage disorders and metabolic disorders. Hypertrophic cardiomyopathy (HCM) is the most frequent primary cardiomyopathy (CMP) and a genetical cause of cardiac hypertrophy. It requires the exclusion of any other cause of LV hypertrophy.

5 June 2024 in Heliyon
Verified
Journal Article
Open access
Davide ToreDavide Tore
Davide Tore
RFRiccardo Faletti
Riccardo Faletti
APAnna Palmisano
Anna Palmisano
SSSara Salto
Sara Salto
KRKatia Rocco
Katia Rocco
MGMarco Gatti
Marco Gatti
Cardiac computed tomography (CCT) has assumed an increasingly significant role in the evaluation of coronary artery disease (CAD) during the past few decades, whereas cardiovascular magnetic resonance (CMR) remains the gold standard for myocardial tissue characterization. The discovery of late myocardial enhancement following intravenous contrast administration dates back to the 1970s with ex-vivo CT animal investigations; nevertheless, the clinical application of this phenomenon for cardiac tissue characterization became prevalent for CMR imaging far earlier than for CCT imaging.

1 December 2024 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
APAnna Palmisano
Anna Palmisano
EBElisa Bruno
Elisa Bruno
GAGiovanni Donato Aquaro
Giovanni Donato Aquaro
CGCarmelo De Gori
Carmelo De Gori
SBSimone Barbieri
Simone Barbieri
AEAntonio Esposito
Antonio Esposito
Mitral annular disjunction (MAD) was a frequent incidental finding at cardiac MRI examinations performed for various clinical indications; longer MAD length and coexisting bileaflet mitral valve prolapse were associated with a higher prevalence of arrhythmia.